openPR Logo
Press release

Specialty Injectable Generics Market Demands and Growth Prediction, Outlook 2018-2026 With Top Key Players Pfizer Inc., Mylan N.V., Teva Pharmaceuticals Industries Ltd., Fresenius SE & Co. KGaA, and Hikma Pharmaceuticals Plc.

02-23-2019 01:27 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Specialty Injectable Generics

Specialty Injectable Generics

Specialty injections are high cost medications or drugs that are used to treat various complex diseases such as cancer, HIV, rheumatoid arthritis, hemophilia, and central nervous system diseases. Specialty injections are often biologics that are produced by biotechnology methods. Specialty drugs are complex to manufacture. Some specialty injectable can be self-administered. Specialty drugs may also be defined as orphan or ultra-orphan drugs under the U.S. Orphan drug act 1983. This was enacted to facilitate development of orphan drugs, which are drugs for rare diseases such as Huntington’s disease, muscular dystrophy, amyotrophic lateral sclerosis, and myoclonus.

Download PDF Brochure of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-pdf/1877

Specialty Injectable Generics Market Drivers:-

New product launches are expected to be a major driver for growth of the specialty injectable generics market. For instance, in 2015, Avatis Plc., a global specialty pharmaceutical company, launched specialty generic injections portfolio. This portfolio includes generic versions of Gemzar, Campostar, Taxotere, and Zometa, which are used for the treatment of cancer.

In 2016, Teva Pharmaceuticals Industries Ltd. launched generic equivalent to Imitrex 1 (sumatriptan) injection, 4mg and 6mg single-dose. Sumatriptan is used in the treatment of acute migraines and acute cluster headaches in adults. Sumatriptan injection can be self-administered subcutaneously into the outer thigh or an arm. Mergers and acquisitions are also expected to boost growth of the specialty injectable generics market size. For instance, in 2014, Sagent Pharmaceuticals Inc., a specialty pharmaceutical company, acquired Omega Laboratories Ltd., a specialty pharmaceutical company, to develop and enhance their specialty injectable portfolio.

In 2015, Endo International Plc., a generic and specialty pharmaceutical company, acquired Par pharmaceutical companies Inc., which markets, develops, and distributes generic drugs in the U.S., to develop and enhance its generic injectable drugs portfolio and to double the revenue generated by its generic division. Prevalence of diseases such as cancer, central nervous system disorders, and chronic diseases are also expected to drive the specialty injectable generics market growth.

Specialty Injectable Generics Market Key Players:-

Key players operating in this market include Pfizer Inc., Mylan N.V., Teva Pharmaceuticals Industries Ltd., Fresenius SE & Co. KGaA, and Hikma Pharmaceuticals Plc. New product launches by key players is expected to drive the specialty injectable generics market growth. For instance, in 2017, Mylan N.V., a global generic and specialty pharmaceuticals company, launched the generic version of Pfizer’s Cerebryx, which is an injectable variety of fasphenytoin sodium.

Request For Customization Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-customization/1877

Specialty Injectable Generics Market Regional Analysis:-

North America is expected to hold dominant position in the global specialty injectable generics market due to mergers and acquisitions. For instance, in May 2018, Impax Laboratories Inc. partnered with Amneal Pharmaceuticals Inc., a specialty pharmaceutical company to develop affordable and more accessible specialty injectable generics. This will lead to the development of new injectable generics for the treatment of various diseases.

New product launches are also expected to boost North America specialty injectable generics market growth. In March 2018, Teva pharmaceutical Industries Ltd. launched generic version of Aloxi injection 0.25mg/5ml called as Palonosetron hydrochloride injection in the U.S. market. Europe is expected to witness growth owing to rising number of cancer patients. According to a study conducted by the World Health Organization (WHO) in 2016, over 753,600 people were diagnosed with cancer in this region.

Asia Pacific specialty injectable generics market is expected to witness significant growth over the forecast period owing to new product launches. For instance, in June 2018, Dr. Reddy’s Laboratories, an Indian pharmaceutical company, launched specialty generic injection Levetiracetram in sodium chloride injection, which is a generic version of HQ Specialty Pharma Corporation’s Levetiracetram in sodium chloride injection.

Mergers and acquisitions is also expected to fuel growth of the market in this region. In 2017, Lupin Ltd. acquired Symbiomix Therapeutics LLC., a pharmaceutical company, to develop and expand in women health segment.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Specialty Injectable Generics Market Demands and Growth Prediction, Outlook 2018-2026 With Top Key Players Pfizer Inc., Mylan N.V., Teva Pharmaceuticals Industries Ltd., Fresenius SE & Co. KGaA, and Hikma Pharmaceuticals Plc. here

News-ID: 1611850 • Views: 462

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Specialty

Global Specialty Zeolites Market, Global Specialty Zeolites Industry, Covid-19 I …
The Specialty Zeolites market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Specialty Zeolites Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Specialty Zeolites market. The report focuses on well-known providers in the global
Global Specialty Wire Sales Market 2018:2025 - MWS Wire, Torpedo Specialty Wire, …
The Specialty Wire Sales market research report is a comprehensive emphasizing study of the industry The Global Specialty Wire Sales market 2018-2025 report offers a extensive and precise estimates and forecasts study of Specialty Wire Sales industry along with the analysis of essential features providing key industry insights to the readers. The Specialty Wire Sales market research report further delivers an methodical outlook of the industry by studying key components impacting
Global Specialty Wire Market Size and Growth Analysis (2019 - 2025) by Top Key P …
Global specialty wire market report is first of its kind research report that covers the overview, summary, market dynamics, competitive analysis, and leading player’s various strategies to sustain in the global market. The specialty wire report covers the five top regions of the globe and countries within, which shows the status of regional development, consisting of market value, volume, size, and price data.  Apart from this, the specialty wire report
Specialty Wire Market 2018-2025 Key Players: MWS Wire, Torpedo Specialty Wire, S …
Specialty Wire Market Summary:Reports Monitor has added new report titled, ‘Global Specialty Wire Market Review 2017-2018 Forecast to 2025 - Analysis by Chemical Type, Technology, Application, End-User, Industry Vertical, and Region’ into its vast depository of research reports. In the first section of the report, the market definition, market overview, product description, product scope, product characterization, and product specification has been discussed. The information presented in this report provides an overview of the
Specialty Surfactants Market
Latest Developments Growing personal care industry in emerging economies and increasing purchasing power of middle class are fuelling the growth of the specialty surfactants market. While stringent environmental regulations regarding the manufacturing of specialty surfactants are hindering the growth of this market. Market Insights Anionic surfactants is poised to account for the largest market share in 2016 and owing to the increased use of green surfactants amphoteric surfactants have registered the highest CAGR.
Specialty Wire 2017 Global Market Key Players – MWS Wire, Torpedo Specialty Wi …
Specialty Wire SWOT Analysis And Forecast 2022 This report studies Specialty Wire in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering MWS Wire Torpedo Specialty Wire Specialty Wire and Cable (SWC) LANOCO Specialty